426 related articles for article (PubMed ID: 22367004)
1. Self-assembled RNA interference microsponges for efficient siRNA delivery.
Lee JB; Hong J; Bonner DK; Poon Z; Hammond PT
Nat Mater; 2012 Feb; 11(4):316-22. PubMed ID: 22367004
[TBL] [Abstract][Full Text] [Related]
2. Mono-arginine Cholesterol-based Small Lipid Nanoparticles as a Systemic siRNA Delivery Platform for Effective Cancer Therapy.
Lee J; Saw PE; Gujrati V; Lee Y; Kim H; Kang S; Choi M; Kim JI; Jon S
Theranostics; 2016; 6(2):192-203. PubMed ID: 26877778
[TBL] [Abstract][Full Text] [Related]
3. siRNA delivery: Loaded-up microsponges.
Grabow WW; Jaeger L
Nat Mater; 2012 Mar; 11(4):268-9. PubMed ID: 22437781
[No Abstract] [Full Text] [Related]
4. Lipid nanoparticles for short interfering RNA delivery.
Leung AK; Tam YY; Cullis PR
Adv Genet; 2014; 88():71-110. PubMed ID: 25409604
[TBL] [Abstract][Full Text] [Related]
5. Polycation-based nanoparticle delivery for improved RNA interference therapeutics.
Howard KA; Kjems J
Expert Opin Biol Ther; 2007 Dec; 7(12):1811-22. PubMed ID: 18034647
[TBL] [Abstract][Full Text] [Related]
6. siRNA release kinetics from polymeric nanoparticles correlate with RNAi efficiency and inflammation therapy via oral delivery.
He C; Yue H; Xu L; Liu Y; Song Y; Tang C; Yin C
Acta Biomater; 2020 Feb; 103():213-222. PubMed ID: 31812844
[TBL] [Abstract][Full Text] [Related]
7. A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy.
Ding Y; Wang W; Feng M; Wang Y; Zhou J; Ding X; Zhou X; Liu C; Wang R; Zhang Q
Biomaterials; 2012 Dec; 33(34):8893-905. PubMed ID: 22979990
[TBL] [Abstract][Full Text] [Related]
8. Structurally modulated codelivery of siRNA and Argonaute 2 for enhanced RNA interference.
Li J; Wu C; Wang W; He Y; Elkayam E; Joshua-Tor L; Hammond PT
Proc Natl Acad Sci U S A; 2018 Mar; 115(12):E2696-E2705. PubMed ID: 29432194
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticle-siRNA: A potential cancer therapy?
Young SW; Stenzel M; Yang JL
Crit Rev Oncol Hematol; 2016 Feb; 98():159-69. PubMed ID: 26597018
[TBL] [Abstract][Full Text] [Related]
10. Polyethylenimine as a promising vector for targeted siRNA delivery.
Nimesh S
Curr Clin Pharmacol; 2012 May; 7(2):121-30. PubMed ID: 22432843
[TBL] [Abstract][Full Text] [Related]
11. Lipid-based Nanocarriers for siRNA Delivery: Challenges, Strategies and the Lessons Learned from the DODAX: MO Liposomal System.
Oliveira ACN; Fernandes J; Gonçalves A; Gomes AC; Oliveira MECDR
Curr Drug Targets; 2019; 20(1):29-50. PubMed ID: 29968536
[TBL] [Abstract][Full Text] [Related]
12. Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung.
Günther M; Lipka J; Malek A; Gutsch D; Kreyling W; Aigner A
Eur J Pharm Biopharm; 2011 Apr; 77(3):438-49. PubMed ID: 21093588
[TBL] [Abstract][Full Text] [Related]
13. Targeted siRNA Delivery Using Lipid Nanoparticles.
Jorge A; Pais A; Vitorino C
Methods Mol Biol; 2020; 2059():259-283. PubMed ID: 31435927
[TBL] [Abstract][Full Text] [Related]
14. Tumor-targeting multifunctional nanoparticles for siRNA delivery: recent advances in cancer therapy.
Ku SH; Kim K; Choi K; Kim SH; Kwon IC
Adv Healthc Mater; 2014 Aug; 3(8):1182-93. PubMed ID: 24577795
[TBL] [Abstract][Full Text] [Related]
15. Cationic liquid crystalline nanoparticles for the delivery of synthetic RNAi-based therapeutics.
Gentile E; Oba T; Lin J; Shao R; Meng F; Cao X; Lin HY; Mourad M; Pataer A; Baladandayuthapani V; Cai D; Roth JA; Ji L
Oncotarget; 2017 Jul; 8(29):48222-48239. PubMed ID: 28637023
[TBL] [Abstract][Full Text] [Related]
16. A Multi-RNAi Microsponge Platform for Simultaneous Controlled Delivery of Multiple Small Interfering RNAs.
Roh YH; Deng JZ; Dreaden EC; Park JH; Yun DS; Shopsowitz KE; Hammond PT
Angew Chem Int Ed Engl; 2016 Mar; 55(10):3347-51. PubMed ID: 26695874
[TBL] [Abstract][Full Text] [Related]
17. Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges.
Gomes-da-Silva LC; Fonseca NA; Moura V; Pedroso de Lima MC; Simões S; Moreira JN
Acc Chem Res; 2012 Jul; 45(7):1163-71. PubMed ID: 22568781
[TBL] [Abstract][Full Text] [Related]
18. Systemic delivery of siRNA with cationic lipid assisted PEG-PLA nanoparticles for cancer therapy.
Yang XZ; Dou S; Sun TM; Mao CQ; Wang HX; Wang J
J Control Release; 2011 Dec; 156(2):203-11. PubMed ID: 21839126
[TBL] [Abstract][Full Text] [Related]
19. T7 peptide-functionalized nanoparticles utilizing RNA interference for glioma dual targeting.
Kuang Y; An S; Guo Y; Huang S; Shao K; Liu Y; Li J; Ma H; Jiang C
Int J Pharm; 2013 Sep; 454(1):11-20. PubMed ID: 23867728
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic potential of RNA interference against cancer.
Takeshita F; Ochiya T
Cancer Sci; 2006 Aug; 97(8):689-96. PubMed ID: 16863503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]